Orlando, FL, United States of America

Tirumalai Kamala



 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tirumalai Kamala

Introduction

Tirumalai Kamala is a notable inventor based in Orlando, FL (US). He has made significant contributions to the field of biomedical research, particularly in the development of models that mimic the neonatal immune system. His work is crucial for advancing pre-clinical assessments of infant immune responses.

Latest Patents

Tirumalai Kamala holds a patent for an "In vitro neonatal biomimetic (nMIMIC) model and methods of using same." This patent focuses on in vitro biomimetic models of the neonatal immune system. These models are designed to assess infant immune cell-mediated and humoral responses to immunogenic stimulation, such as vaccination. The models include one that comprises cord blood-derived T follicular helper cells and B cells, and another that includes cord blood-derived dendritic cells and CD4+ T cells. They can be utilized to evaluate candidate vaccines through the analysis of cellular responses to antigen and vaccine exposure. He has 1 patent to his name.

Career Highlights

Tirumalai Kamala is currently associated with Sanofi Pasteur Vaxdesign Corporation, where he applies his expertise in immunology and vaccine development. His innovative work has the potential to significantly impact infant healthcare and vaccination strategies.

Collaborations

Tirumalai collaborates with talented professionals in his field, including Evan Gomes and Luis Mosquera. Their combined efforts contribute to the advancement of research in neonatal immunology.

Conclusion

Tirumalai Kamala's contributions to the field of biomedical research, particularly through his patent on neonatal biomimetic models, highlight his role as an influential inventor. His work is paving the way for improved understanding and assessment of infant immune responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…